期刊文献+

有效PGK1短发夹RNA序列的筛选 被引量:1

Screening of the sequence of short hairpin RNA-specific PGK1 gene
原文传递
导出
摘要 目的筛选有效抑制磷酸甘油酸激酶1(PGK1)基因的短发夹核糖核酸(shRNA)序列。方法针对PGK1的不同基因区域设计4个shRNA序列,应用LipofectamineTM2000方法转染至胶质瘤细胞株U251细胞,荧光显微镜下观察shRNA的转染效率。采用RT-PCR方法检测PGK1的mRNA表达,Western blot方法检测PGK1的蛋白表达。结果针对PGK1-homo-441位点的shRNA4(5′-GCAAGGATGTTCTGTTCTTGA-3′)能更有效地抑制PGK1的mRNA及蛋白表达。结论shRNA4是能有效抑制PGK1表达的序列,可用于PGK1的功能研究。 Objective To screen the effective sequence of short hairpin RNA (shRNA) inhibiting PGK1 gene. Methods The shRNAs for PGK1 were transfected to U251 cells using lipofectamineTM 2000. Transfeetion efficiency was confirmed by inverted fluorescent microscopy. RT-PCR and Western blot analysis were performed to detect the expressions of PGK1 mRNA and protein. Results The 4th shRNA in allusion PGKl-homo-441 was more efficient in inhibiting the expressions of PGK1 mRNA and protein. Conclusion The 4th shRNA can efficiently inhibit the production of PGK1, which can be used for studying the effect of PGK1 in the future.
出处 《江苏医药》 CAS 北大核心 2013年第16期1861-1864,共4页 Jiangsu Medical Journal
基金 国家自然科学基金(NSFC81172390) 南京市医学科技发展项目(ZKX10021)
关键词 短发夹核糖核酸 磷酸甘油酸激酶1基因 Short hairpin RNA PGK1 gene
  • 相关文献

参考文献8

  • 1Schwartzbaum JA, Fisher JL, Aldape KD, et al. Epidemiology and molecular pathology of glioma[J]. Nat Clin Pract Neurol, 2006,2(9) :494-503.
  • 2Grossman SA, Batara JF. Current management of glioblastoma multiforme[J]. Semin Oncol, 2004,31 (5) : 635-644.
  • 3Preusser M, Ribaupierre de S, Wohrer A, et al. Currentconcepts and management of glioblastomaI-J]. Ann Neurol, 2011,70(1) :9-21.
  • 4Han M, Wang H, Zhang HT, et al. Expression of TIP-1 confers radioresistance of malignant glioma cells [J]. PLoS One, 2012,7(9) : e45402.
  • 5Yan H, Yang K, Xiao H, et al. Over-expression of cofilin-1 and phosphoglycerate kinase 1 in astrocytomas involved in patho- genesis of radioresistance[J]. CNS Neuroscl Ther, 2012, 18 (9) : 729-736.
  • 6Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method[J]. Methods,2001,25(4) :402-408.
  • 7Matzke M, Matzke AJ, Kooter JM. RNA: guiding gene silen- cing[J]. Science, 2001,293 (5532) : 1080-1083.
  • 8McManus MT, Sharp PA. Gene silencing in mammals by small interfering RNAs[J]. Nat Rev Genet, 2002,3 (10) z 737-747.

同被引文献14

  • 1Cancer incidence in five continents. Volume Ⅷ [ M ]. IARC Sci Publ,2002 : 1-781.
  • 2Krakstad C, Chekenya M. Survival signalling and apoptosis resistance in glioblastomas:opportunities for targeted therapeutics [ J]. Mol Cancer,2010,9 : 135.
  • 3Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma [ J ]. Neurology, 1980,30:907.
  • 4Vandeberg J L. The phosphoglycerate kinase isozyme system in mammals: biochemical, genetic, developmental, and evolutionary aspects [ J ]. Isozymes Curr Top Biol Med Res, 1985,12 : 133.
  • 5Ahmad S S, Glatzle l, Bajaeifer K,et al. Phosphoglycerate kinase 1 as a promoter of metastasis in colon cancer [ J]. Int J Oncol, 2013,43:586.
  • 6Wang J, Ying G, Wang J, et al. Characterization of phospho- glycerate kinase-1 expression of stromal cells derived from tumor microenvi-ronment in prostate cancer progression[ J]. Cancer Res, 2010,70:471.
  • 7Duan Z, Lamendola D E, Yusuf R Z,et al. Overexpression of human phosphoglycerate kinase 1 ( PGK1 ) induces a muhidrug resistance phenotype[ J ]. Anticancer Res ,2002,22 : 1933.
  • 8Lin TY, Chang JT, Wang HM, et al. Proteomics of the radioresistant phenotype in head-and-neck cancer: Gp96 as a novel prediction marker and sensitizing target for radiotherapy [ J ]. Int J Radiation Oncology Biol Phys, 2010,78:246.
  • 9Semenza G L. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics [ J ]. Oncogene,2010 ,29 :625.
  • 10Semenza GL, Roth PH, Fang HM, et al. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1 [J]. J Biol Chem,1994,269:23757.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部